Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-06-07
1998-06-23
Kight, John
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 111, A61K 5100, A61M 3614
Patent
active
057701792
ABSTRACT:
This invention relates to radiodiagnostic agents and reagents for preparing such agents, and also methods for producing radiolabeled radiodiagnostic agents. Specifically, the invention relates to technetium-99m (.sup.99m Tc) labeled agents, methods and kits for making the agents, and methods for using the agents to image pathological sites, including sites of infection, inflammation, cancer and atherosclerosis in a mammalian body. Specifically the agents and reagents are derivatives of oligosaccharides, more specifically .beta.-glucans.
REFERENCES:
patent: 4002730 (1977-01-01), Hartman et al.
patent: 4431626 (1984-02-01), Henze
patent: 4835046 (1989-05-01), Milbrath et al.
patent: 5422095 (1995-06-01), Hushiguchi et al.
patent: 5508020 (1996-04-01), Dean et al.
patent: 5561220 (1996-10-01), Dean et al.
Diatide, Inc.
Jones Dameron
Kight John
LandOfFree
Radiolabeled glucans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled glucans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled glucans will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1392400